Prehospitalization inhaled corticosteroid use in patients with COPD or asthma

被引:31
|
作者
Jackevicius, C
Joyce, DP
Kesten, S
Chapman, KR
机构
[1] TORONTO HOSP,WESTERN DIV,DEPT PHARM,TORONTO,ON M5T 2S8,CANADA
[2] TORONTO HOSP,ASTHMA CTR,TORONTO,ON M5T 2S8,CANADA
[3] RUSH PRESBYTERIAN ST LUKES MED CTR,CHICAGO,IL 60612
关键词
D O I
10.1378/chest.111.2.296
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Guidelines for the treatment of obstructive lung diseases suggest a primary role of inhaled corticosteroids (ICs) in asthma, but only a minor role in COPD. However, surveys of physicians' prescribing habits have suggested that there is little difference in the use of ICs between these two conditions. Objectives: To determine the prevalence of IC use before and during hospitalization among patients with COPD or asthma. Design: Retrospective chart review. Setting: Tertiary care university teaching hospital. Patients: Adult inpatients, aged 18 or older, with physician-diagnosed COPD or asthma. Measurements: Patient-reported prescription drug use at hospital admission, and medical chart record of in-hospital and discharge prescriptions. Results: Of 350 charts reviewed, 102 patients were admitted to the hospital for unstable COPD, 133 patients had stable COPD, 36 patients were admitted with unstable asthma, and 79 patients had stable asthma. At hospital admission, 48% of unstable COPD patients, 26% of stable COPD patients, 56% of unstable asthma patients, and 44% of stable asthma patients reported having a current prescription for ICs. The proportion of all asthmatic patients reporting a current prescription for ICs at admission (48%) was significantly higher than the proportion of all COPD patients receiving an IC at admission (35%). However, there was no significant difference in the proportion of COPD and asthma patients with a current prescription of any form of corticosteroid (oral or inhaled). The proportion of COPD patients likely to respond to IC therapy is significantly different from the observed use at hospital admission. Conclusions: The proportion of patients found to be using ICs is much higher than the proportion expected to respond. There was little difference in the use of ICs for asthma and COPD patients at hospital admission. Most COPD patients using an IC were receiving the regimen on admission to hospital, indicating that there is need for education in the community and in the hospital, indicating that there is need for education in the community and in the hospital regarding use of ICs in COPD patients.
引用
收藏
页码:296 / 302
页数:7
相关论文
共 50 条
  • [1] Inhaled corticosteroid related pneumonia in real world among the patients with asthma and COPD
    Kwon, Jae-Woo
    Go, Tae Hwa
    Han, Seon-Sook
    Lee, Seung-Hwan
    Kim, Young-Ju
    Lee, Seung-Joon
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [2] Inhaled Corticosteroid Use Among COPD Patients in Primary Care in Spain
    Miravitlles, Marc
    Roman-Rodriguez, Miguel
    Ribera, Xavier
    Ritz, John
    Izquierdo, Jose Luis
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 245 - 258
  • [3] Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia
    Singanayagam, A.
    Chalmers, J. D.
    Akram, A. R.
    Hill, A. T.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (01) : 36 - 41
  • [4] THE USE OF INHALED CORTICOSTEROID AEROSOLS IN THE TREATMENT OF ASTHMA
    SPECTOR, SL
    [J]. HOSPITAL FORMULARY, 1983, 18 (04): : 421 - &
  • [5] Parental attitudes to inhaled corticosteroid use for asthma
    Gordon, A
    Lewis, V
    O'Connor, K
    Wade, K
    Reznik, M
    Ozuah, PO
    [J]. PEDIATRIC RESEARCH, 2004, 55 (04) : 605A - 605A
  • [6] Inhaled corticosteroid use and bone-mineral density in patients with asthma
    Wong, CA
    Walsh, LJ
    Smith, CJP
    Wisniewski, AF
    Lewis, SA
    Hubbard, R
    Cawte, S
    Green, DJ
    Pringle, M
    Tattersfield, AE
    [J]. LANCET, 2000, 355 (9213): : 1399 - 1403
  • [7] Which patients with COPD need an inhaled corticosteroid?
    Boylan, Paul M.
    [J]. JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2024, 37 (02): : 18 - 21
  • [8] Inhaled corticosteroid use and the incidence of lung cancer in COPD
    Suissa, Samy
    Dell'Aniello, Sophie
    Gonzalez, Anne, V
    Ernst, Pierre
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (02)
  • [9] A retrospective evaluation of inhaled corticosteroid use for COPD patients receiving systemic corticosteroids
    Steuber, Taylor
    [J]. PHARMACOTHERAPY, 2015, 35 (11): : E284 - E285
  • [10] Inhaled corticosteroid use and asthma hospitalization rates in Japan
    Odajima, Y
    Kuwabara, H
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2006, 34 (02) : 208 - 214